Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect
Creator
Wang, Xiao
Zhang, Yongmin
He, Xirui
Wu, Shaoping
Xie, Jing
Zhao, Zefeng
Zheng, Xiaohui
Li, Chenyang
Dai, Xufen
Fan, Peinan
Feng, Ying
Ma, Cong
Nie, Zhuang
Qian, Mingcheng
Tian, Jiale
Source
Elsevier; Medline; PMC
abstract
Abstract The pyrazolone structural motif is a critical element of drugs aimed at different biological end-points. Medicinal chemistry researches have synthesized drug-like pyrazolone candidates with several medicinal features including antimicrobial, antitumor, CNS (central nervous system) effect, anti-inflammatory activities and so on. Meanwhile, SAR (Structure-Activity Relationship) investigations have drawn attentions among medicinal chemists, along with a plenty of analogues have been derived for multiple targets. In this review, we comprehensively summarize the biological activity and SAR for pyrazolone analogues, wishing to give an overall retrospect and prospect on the pyrazolone derivatives.
has issue date
2020-01-15
(
xsd:dateTime
)
bibo:doi
10.1016/j.ejmech.2019.111893
bibo:pmid
31761383
has license
els-covid
sha1sum (hex)
cb16d307afaecebd683e6d74c8b501ed54b0c9a4
schema:url
https://doi.org/10.1016/j.ejmech.2019.111893
resource representing a document's title
Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect
has PubMed Central identifier
PMC7115706
has PubMed identifier
31761383
schema:publication
European Journal of Medicinal Chemistry
resource representing a document's body
covid:cb16d307afaecebd683e6d74c8b501ed54b0c9a4#body_text
is
schema:about
of
named entity 'element'
named entity 'analogues'
named entity 'pyrazolone'
named entity 'structural motif'
named entity 'REVIEW'
named entity 'ANTITUMOR'
named entity 'ACTIVITY'
named entity 'INCLUDING'
named entity 'IS A'
named entity 'FEATURES'
named entity 'END'
named entity 'STRUCTURAL MOTIF'
named entity 'ANTI-INFLAMMATORY'
named entity 'PYRAZOLONE'
named entity 'NERVOUS SYSTEM'
named entity 'CRITICAL'
named entity 'INVESTIGATIONS'
named entity 'STRUCTURAL MOTIF'
named entity 'PROSPECT'
named entity 'PYRAZOLONE'
named entity 'MEDICINAL CHEMISTRY'
named entity 'SAR'
named entity 'DRUG'
named entity 'PYRAZOLONE DERIVATIVES'
named entity 'ELEMENT'
named entity 'HAVE'
named entity 'OVERALL'
named entity 'PROSPECT'
named entity 'CHEMISTS'
named entity 'EFFECT'
named entity 'DERIVED'
named entity 'DRUGS'
named entity 'TARGETS'
named entity 'POINTS'
named entity 'MEDICINAL CHEMISTRY'
named entity 'DIFFERENT'
named entity 'RELATIONSHIP'
named entity 'ANTIMICROBIAL'
named entity 'BIOLOGICAL'
named entity 'BIOLOGICAL ACTIVITY'
named entity 'PLENTY'
named entity 'SYNTHESIZED'
named entity 'MULTIPLE'
named entity 'ACTIVITIES'
named entity 'LIKE'
named entity 'CNS'
named entity 'ATTENTIONS'
named entity 'targets'
named entity 'anti-inflammatory'
named entity 'retrospect'
named entity 'CNS'
named entity 'Pyrazolone'
named entity 'potency'
named entity 'E. coli'
named entity 'thiourea derivatives'
named entity 'protein'
named entity 'TNF-a'
named entity 'pyrans'
named entity 'potency'
named entity 'benzyl'
named entity 'cytotoxic'
named entity 'pharmacological'
named entity 'carbonyl group'
named entity 'nitrogen'
named entity 'heterocyclic'
named entity 'potency'
named entity 'antitumor'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 15
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software